Cargando…

A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms

INTRODUCTION: The RNA N6-methyladenosine (m6A) regulators play a crucial role in tumorigenesis and could be indicators of prognosis and therapeutic targets in various cancers. However, the expression status and prognostic value of m6A regulators have not been studied in pancreatic neuroendocrine neo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xianlong, Mo, Shengwei, Zong, Liju, Yu, Shuangni, Lu, Zhaohui, Chen, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808770/ https://www.ncbi.nlm.nih.gov/pubmed/35609514 http://dx.doi.org/10.1159/000525228

Ejemplares similares

Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma
por: Chen, Xianlong, et al.
Publicado: (2022)

Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma
por: Chen, Xianlong, et al.
Publicado: (2022)

Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas
por: Zong, Liju, et al.
Publicado: (2023)

Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma
por: Chen, Xianlong, et al.
Publicado: (2022)

PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules
por: Zhang, Yue, et al.
Publicado: (2022)

The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma
por: Ma, Heng, et al.
Publicado: (2023)

Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
por: Shao, Huilin, et al.
Publicado: (2021)

EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms
por: Venugopal, Abhirami, et al.
Publicado: (2022)

Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma
por: Ma, Heng, et al.
Publicado: (2023)

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
por: Chan, Chang S., et al.
Publicado: (2018)

Prognostic role of lymphocyte-to-monocyte ratio in pancreatic neuroendocrine neoplasms
por: Zhou, Wentao, et al.
Publicado: (2020)

Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
por: Zhuge, Xiaoling, et al.
Publicado: (2020)

A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms
por: Gao, Yong, et al.
Publicado: (2018)

Effectiveness and Prognostic Factors of Everolimus in Patients with Pancreatic Neuroendocrine Neoplasms
por: Kurita, Yusuke, et al.
Publicado: (2022)

Imaging of Pancreatic Neuroendocrine Neoplasms
por: Chiti, Giuditta, et al.
Publicado: (2021)

Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study
por: Yu, Shuangni, et al.
Publicado: (2022)

DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association
por: Lakis, Vanessa, et al.
Publicado: (2021)

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors
por: Simon, Tincy, et al.
Publicado: (2022)

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms
por: Liu, Man, et al.
Publicado: (2023)

Surgical management of pancreatic neuroendocrine neoplasms
por: Partelli, Stefano, et al.
Publicado: (2014)

Imaging presentation of pancreatic neuroendocrine neoplasms
por: Ciaravino, Valentina, et al.
Publicado: (2018)

An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
por: Bevere, Michele, et al.
Publicado: (2023)

Management of Functional Pancreatic Neuroendocrine Neoplasms
por: Magi, Ludovica, et al.
Publicado: (2023)

Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?
por: Chen, Jingci, et al.
Publicado: (2021)

Predictive value of the preoperative prognostic nutritional index for postoperative progression in patients with pancreatic neuroendocrine neoplasms
por: Fu, Mengfei, et al.
Publicado: (2022)

Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms
por: Della Monica, Rosa, et al.
Publicado: (2022)

Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms
por: Palmieri, Lola-Jade, et al.
Publicado: (2020)

Current update on imaging for pancreatic neuroendocrine neoplasms
por: Segaran, Nicole, et al.
Publicado: (2021)

Advances in medical treatment for pancreatic neuroendocrine neoplasms
por: Li, Yuan-Liang, et al.
Publicado: (2022)

Reconsideration of operative indications in pancreatic neuroendocrine neoplasms
por: Abe, Kodai, et al.
Publicado: (2022)

Development of a four-gene prognostic model for pancreatic cancer based on transcriptome dysregulation
por: Yan, Jie, et al.
Publicado: (2020)

Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?
por: Hijioka, Susumu, et al.
Publicado: (2014)

Early-onset pancreatic neuroendocrine neoplasms: A distinct disease with improved survival compared with old individuals
por: Yang, Zhen, et al.
Publicado: (2023)

Whole-exome sequencing of calcitonin-producing pancreatic neuroendocrine neoplasms indicates a unique molecular signature
por: Döring, Claudia, et al.
Publicado: (2023)

CD56 Expression Is Associated with Biological Behavior of Pancreatic Neuroendocrine Neoplasms
por: Chen, Xin, et al.
Publicado: (2020)

Complete excision of a large pancreatic neuroendocrine neoplasm
por: Darko, Rudolph, et al.
Publicado: (2018)

Role of Endoscopic Ultrasound in the Diagnosis of Pancreatic Neuroendocrine Neoplasms
por: Ishii, Tatsuya, et al.
Publicado: (2021)

Duodenal Metastasis from a Pancreatic Neuroendocrine Neoplasm
por: Koiwai, Akinobu, et al.
Publicado: (2020)

Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms
por: Kaur, Jasmeet, et al.
Publicado: (2023)

Actinin-4 splice variant - a complementary diagnostic and prognostic marker of pancreatic neuroendocrine neoplasms
por: Xu, Xiaojun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tohde1hbahaq1dtm98o1lta0sd